Abstract:Interrupted ER homeostasis contributes to the etiology of obesity cardiomyopathy although it remains elusive how ER stress evokes cardiac anomalies in obesity. Our study evaluated the impact of ER stress inhibition on cardiac anomalies in obesity. Lean and ob/ob obese mice received chemical ER chaperone tauroursodeoxycholic acid (TUDCA, 50 mg/kg/d, p.o.) for 35 days prior to evaluation of glucose sensitivity, echocardiographic, myocardial geometric, cardiomyocyte mechanical and subcellular Ca 2+ property, mitochondrial integrity, oxidative stress, apoptosis, and ferroptosis. Intracellular Ca 2+ governing domains including sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) were monitored by 45 Ca 2+ uptake and immunoblotting. Our results noted that TUDCA alleviated myocardial remodeling (fibrosis, hypertrophy, enlarged LVESD), echocardiographic anomalies (compromised fractional shortening and ejection fraction), cardiomyocyte contractile dysfunction (amplitude and velocity of cell shortening, relengthening time) and intracellular Ca 2+ anomalies (compromised subcellular Ca 2+ release, clearance and SERCA function), mitochondrial damage (collapsed membrane potential, downregulated mitochondrial elements and ultrastructural alteration), ER stress (GRP78, eIF2α and ATF4), oxidative stress, apoptosis and ferroptosis [downregulated SLC7A11, GPx4 and upregulated transferrin receptor (TFRC)] without affecting global glucose sensitivity and serum Fe 2+ in obese mice. Obesity-evoked change in HSP90, phospholamban and Na + -Ca 2+ exchanger was spared by the chemical ER chaperone. Moreover, in vitro results noted that TUDCA, PERK inhibitor GSK2606414, TFRC neutralizing antibody and ferroptosis inhibitor LIP1 mitigated palmitic acid-elicited changes in lipid peroxidation and mechanical function. Our findings favored a role for ferroptosis in obesity cardiomyopathy downstream of ER stress.

Chemical Chaperones Reduce Endoplasmic Reticulum Stress and Prevent Mutant HFE Aggregate Formation

Iron Chelators Reverse Organ Damage in Type 4B Hereditary Hemochromatosis Case Reports

Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death

Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants

Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria

CFTR suppressing hyperhomocysteinemia-induced hepatocyte damage in ApoE-/-mice

Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity

Chemical and pharmacological chaperones as new therapeutic agents

Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes

Enhancement of Ubiquitin Conjugating Activity Promotes the Clearance of Aggregation‐prone Mutant Proteins in Living Cells

The therapeutic potential of chemical chaperones in protein folding diseases

Chemical chaperones: mechanisms of action and potential use

HLH-30/TFEB rewires the chaperone network to promote proteostasis under conditions of Coenzyme A and Iron-Sulfur Cluster Deficiency

Chemical Chaperone 4-Phenylbutyrate Prevents Endoplasmic Reticulum Stress Induced by T17m Rhodopsin

Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis

Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions

The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome

Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations

Chemical chaperone rescue of mutant human cystathionine β-synthase

Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrel

Inhibition of ER Stress Using Tauroursodeoxycholic Acid Rescues Obesity-Evoked Cardiac Remodeling and Contractile Anomalies through Regulation of Ferroptosis